Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co IncfiledCriticalMerck & Co Inc
Publication of TW200500338ApublicationCriticalpatent/TW200500338A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyrrole Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present invention is directed to phenylalanine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
TW092136707A2003-06-192003-12-24Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
TW200500338A
(en)